MS Cases Double in England Over 20 Years; Life Expectancy Rises
Multiple sclerosis spasticity cannabis treatments are gaining attention as MS cases double in England over 20 years. Improved survival rates mean more patients live longer with chronic symptoms. Cannabis therapies offer promising options for managing…
Variations in p21 Protein May Explain Why Some MS Types Progress Faster
Emerging research on multiple sclerosis biomarkers highlights the role of p21 protein variations in disease progression. Understanding these biomarkers may help identify patients at higher risk for aggressive MS types. This insight supports the…
Mapping the Clinical Trial Landscape for Cannabinoids in Neurology: A Registry-Based Systematic Review
This systematic review of cannabinoid clinical trials neurological disorders highlights research focused on Multiple Sclerosis, Fibromyalgia, and Parkinson's Disease. It reveals challenges due to inconsistent protocols and dosing across studies. The…
Exercises to Strengthen Chest Muscles May Improve Lung Function in MS
Respiratory function exercise therapy is emerging as a promising approach to improve lung function in MS patients. Targeted chest muscle strengthening exercises may help reduce respiratory complications common in multiple sclerosis. This…
Discrepancies between subjective and objective cognition in persons with multiple sclerosis: Exploring the role of cannabis use.
This study investigates cannabis cognitive effects multiple sclerosis patients experience, revealing discrepancies between subjective complaints and objective testing. Cannabis users with MS report greater perceived cognitive deficits than non-users.…
Cannabis for MS Spasticity: A Systematic Review With Critically Unreliable Pooled Estimates
This cannabis MS spasticity review examines nine trials with 2,544 patients but finds critically unreliable pooled estimates due to extreme heterogeneity. The meta-analysis reports numerically implausible effect sizes and suspected publication bias.…
Therapeutic Effects of a Sesquiterpene-Rich Cannabis Essential Oil on Neuroinflammation
This study highlights the effects of a sesquiterpene-rich essential oil cannabis on neuroinflammation and symptom relief in multiple sclerosis models. The essential oil acts through CB2 receptor pathways to provide neuroprotection. These findings suggest…
Enhancing Endocannabinoid System for Residual Disease in MS
This clinical study endocannabinoid system approach addresses residual disease in relapse-free multiple sclerosis patients. High-efficacy therapies reduce relapses but symptoms persist. Enhancing the endocannabinoid system offers new treatment insights.